Voyager Therapeutics Inc (VYGR) — Cash Flow Reinvestment Rate
Voyager Therapeutics Inc (VYGR) has a Cash Flow Reinvestment Rate of 1.67x as of March 2024, reinvesting $98.21 Million (capex $2.14 Million plus investments $-96.06 Million) from operating cash flow of $58.77 Million. See VYGR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Voyager Therapeutics Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Voyager Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see Voyager Therapeutics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Voyager Therapeutics Inc (2015–2023)
Year-by-year capital reinvestment analysis for Voyager Therapeutics Inc. See VYGR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.86x | $144.90 Million | $77.92 Million | $3.26 Million | ▼ -0.2% |
| 2019 | 1.86x | $90.65 Million | $48.67 Million | $7.72 Million | ▼ -60.5% |
| 2015 | 4.72x | $194.77 Million | $41.30 Million | $1.03 Million | — |